The effects of endothelin-a receptor blockade during the progression of pacing-induced congestive heart failure

Journal of the American College of Cardiology

Volumn 32, Issue 6, 1998, Pages 1779-1786

  Saad, Daniel ^a   Mukherjee, Rupak ^a   Thomas, Patrick B ^a   Iannini, Julie P ^a   Basler, Charles G ^a   Hebbar, Latha ^a   Seung Jun, O ^a   Moreland, Suzanne ^b   Webb, Maria L ^b   Powell, James R ^b   Spinale, Francis G ^a,c  

^a Division of Pediatric Surgery   (United States)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMS 193884; CALCIUM; CATECHOLAMINE; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ISOPRENALINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOSE RESPONSE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART PACING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SWINE; SYSTEMIC VASCULAR RESISTANCE;

ANIMALS; CARDIAC PACING, ARTIFICIAL; DISEASE PROGRESSION; HEART; HEART FAILURE, CONGESTIVE; MYOCARDIUM; NEUROTRANSMITTER AGENTS; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; SWINE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0032533832     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00439-2     Document Type: Article

References (32)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Kramer BK, Nishida M, Kelly RA, Smith TW. Endothelins: myocardial actions of a new class of cytokines. Circulation 1992;85:350-6.
3. +2 sensitization in vascular smooth muscle. Eur J Pharmacol 1995;289:197-204.
4. Li K, Stewart DJ, Rouleau JL. Myocardial contractile actions of endothelin-1 in rat and rabbit papillary muscles: role of endocardial endothelium. Circ Res 1991;69:301-12.
5. Takanashi M, Endoh M. Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol 1991;261: H611-9.
6. Love MP, McMurray JJV. Endothelin in chronic heart failure: current position and future prospects. Cardiovasc Res 1996;31:665-74.
7. Kelly RA, Eid H, Kramer BK, et al. Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway. J Clin Invest 1990;86:1164-71.
8. Takanashi M, Endoh M. Concentration and time dependence of phospho-inositide hydrolysis induced by endothelin-1 in relation to the positive inotropic effect in the rabbit ventricular myocardium. J Pharmacol Exp Ther 1992;262:1189-94.
9. +2]i transients, pHi, and contraction in ventricular myocytes. Am J Physiol 1993;265:H793-800.
10. Lerman A, Kubo SH, Tschumperlin LK, Burnett JC. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol 1992;20:849-53.
11. Kiowski W, Sutsch G, Hunziker P, et al. Evidence for endothelin-1 mediated vasoconstriction in severe chronic heart failure. Lancet 1996;346:732-6.
12. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504-9.
13. Wei CM, Lerman A, Rodeheffer RJ, et al. Endothelin in human congestive heart failure. Circulation 1994;89:1580-6.
14. Nootens M, Kaufmann I, Rector T, et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 1995; 26:1581-5.
15. Armstrong PW, Stopps TP, Ford SE, DeBold AJ. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation 1986;74: 1075-84.
16. Spinale FG, de Gasparo M, Whitebread S, et al. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing induced heart failure: I. effects on left ventricular performance and neurohormonal systems. Circulation 1997;96:2385-96.
17. Spinale FG, Holzgrefe HH, Mukherjee R, et al. Angiotensin converting enzyme inhibition and the progression of congestive cardiomyopathy: effects on left ventricular and myocyte structure and function. Circulation 1995;92: 562-8.
18. Thomas PB, Liu ECK, Webb ML, Mukherjee R, Spinale FG. Evidence of the endothelin-1 autocrine loop in cardiac myocytes: relation to contractile function with congestive heart failure. Am J Physiol 1996;40:H2629-73.
19. Spinale FG, Walker JD, Mukherjee R, Iannini JP, Keever AT, Gallagher KP. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits: beneficial effects on left ventricular and myocyte function. Circulation 1997;95:1918-29.
20. Spinale FG, Fulbright BM, Mukherjee R, et al. Relationship between ventricular and myocyte function with tachycardia-induced cardiomyopathy. Circ Res 1992;71:174-87.
21. Tanaka R, Fulbright BM, Mukherjee R, Burchell SA, Zile MR, Spinale FG: The cellular basis for the blunted response to β-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy. J Mol Cell Cardiol 1993;25:1215-33.
22. Travill CM, Williams TDM, Pate P, et al. Hemodynamic and neurohormonal response in heart failure produced by rapid ventricular pacing. Cardiovasc Res 1992;26:783-90.
23. Benedict CR, Weiner DH, Johnstone DE, et al. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the studies of left ventricular dysfunction (SOLVD) registry. J Am Coll Cardiol 1993;22:146A-53A.
24. Bristow MR, Ginsburg R, Umans V, et al. β1 and β2 Adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1-receptor downregulation in heart failure. Circ Res 1986;59:297-309.
25. Poole-Wilson PA. Relation of pathophysiological mechanisms to outcome in heart failure. J Am Coll Cardiol 1993;22:4:22A-9A.
26. Cohn JN, Johnson GR, Shabetai R, et al. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation 1993;87:V15-6.
27. Weber KT, Janicki JS. Instantaneous force-velocity length relationships in isolated dog heart. Am J Physiol 1977;232:H241-9.
28. Weber KT, Janicki JS, Hefner LL. Left ventricular force-length relations of isovolumic and ejecting contractions. Am J Physiol 1976;231:337-43.
29. Teerlink JR, Loffler BM, Hess P, Maire JP, Clozel M, Clozel JP. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure: acute effects of the endothelin receptor antagonist RO 47-0203 (bosentan). Circulation 1994;90:2510-8.
30. Sakai S, Miyauchi T, Sakurai T, et al. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Circulation 1996;93:1214-22.
31. Roubert P, Gilliard V, Plas P, Guillon JM, Chabrier PE, Braquet P. Angiotensin-II and phorbol esters potently down regulate endothelin (ET-1) binding sites in vascular smooth muscle cells. Biochem Boiphys Res Commun 1989;164:809-15.
32. Hinton RB, Hebbar L, Cox MH, et al. Left ventricular regional myocyte contractility in normal and heart failure states. J Mol Cell Cardiol 1997;29: 1939-46.